Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

RSS icon

FDA Clears Siemens Mammography System

Siemens Healthcare has announced that the Food and Drug Administration (FDA) has cleared the MAMMOMAT Inspiration Prime Edition, which lowers patient radiation dose up to 30 percent without compromising image quality.

GE Healthcare and Konica Minolta agree to collaborate on a DR retrofit global distribution agreement, enhancing strategic alliance

GE Healthcare (NYSE: GE) and Konica Minolta Inc. have signed a global distribution agreement (*) of Konica Minolta’s AeroDR cassette-size digital x-ray imaging retrofit. Having built a collaborative relationship for nearly ten years related to the sales of computed radiography (CR)1 in the United States, the two partners have now agreed to expand their strategic alliance, with GE Healthcare distributing AeroDR not just within the United States, but globally as well, using GE Healthcare sales channels.

SEC charges Imaging3 + CEO with fraud

The Securities and Exchange Commission (SEC) charged Imaging3 and its founder and CEO Dean Janes with fraud. According to a June 25 release issued by the SEC, Janes made misleading statements regarding the FDA’s view of its imaging device during a November 2010 conference call.

TBI patients 30% more likely to suffer ischemic stroke

Traumatic brain injury (TBI) has been associated with subsequent ischemic stroke, a finding that could spur stroke prevention efforts in young trauma patients, according to a study published online June 26 in Neurology.

Fused PET and MR make the grade in pediatric brain cancers

A connection between cerebral blood volume (CBV) and tumor metabolism in 3D PET and MR characterized a range of pediatric brain tumors. The two modalities were found to sync complementary functional and metabolic information in 94 percent of cases and could have an impact on risk stratification and prognosis with further study, according to research published June 25 in the Journal of Nuclear Medicine.

Advanced prostate cancer treatments often used on patients who won’t benefit

Advanced treatment technologies for prostate cancer are increasingly being used on the wrong patients, according to a study published June 26 in JAMA.

Phantom fluids: Finding a solution for PET/MR

Steady advancements in simultaneous PET/MR technology make the need for new phantom designs more salient, but the challenge is tricky due to the physics involved in MR imaging. While PET research usually involves watery models, glycols in combination with precise adjustments in tracer composition may be the ideal solution, according to a study published June 21 in the Journal of Nuclear Medicine.

No bones about it: Automated subtraction protocol removes bony pixels from CTA images

A single-source, dual-energy subtraction CT angiography (CTA) protocol can be optimized to provide fully automatic subtraction of bone and brain parenchyma from contrast-enhanced scans of patients with cerebrovascular disorders, according to a study published June 7 in Academic Radiology.

Displaying 5601 - 5608 of 23559

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.